SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 16.30 |
| Enterprise Value ($M) | 2.88 |
| Book Value ($M) | 34.70 |
| Book Value / Share | 1.25 |
| Price / Book | 0.47 |
| NCAV ($M) | 29.68 |
| NCAV / Share | 1.07 |
| Price / NCAV | 0.55 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.27 |
| Return on Assets (ROA) | -0.21 |
| Return on Equity (ROE) | -0.25 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.81 |
| Current Ratio | 5.81 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 37.95 |
| Assets | 42.98 |
| Liabilities | 8.28 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Migdal Insurance & Financial Holdings Ltd. | 5.30 | 0.00 | |
| 13G/A | Phoenix Holdings Ltd. | 8.87 | -4.07 | |
| 13G/A | Armistice Capital, Llc | 4.99 | -31.47 | |
| 13D/A | Arkin Moshe | 60.80 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 5,584 | 12,078 | 46.23 | |
| 7,281 | 35,861 | 20.30 | |
| 7,270 | 34,618 | 21.00 | |
| 100 | 10,034 | 1.00 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SGMO – Sangamo Therapeutics, Inc. | SHPH – Shuttle Pharmaceuticals Holdings, Inc. |
| SILO – Silo Pharma, Inc. | SLRX – Salarius Pharmaceuticals, Inc. |
| SLS – SELLAS Life Sciences Group, Inc. |
Financial data and stock pages provided by
Fintel.io